Alternatives to Edison Software

Email service provider.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

AI-guided drug discovery platform for tissue-targeted medicines.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

AI-powered platform for designing novel molecular structures for new medicines.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

A vertically-integrated procurement platform for the life sciences industry.

A global leader in clinical pharmacology and bioanalytical sciences.

AI-powered knowledge discovery for life sciences.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

Pioneering vision restoration therapies for severe retinal degenerations.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

AI-driven predictive modeling company focused on biology and life sciences.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

Building General Biological Intelligence

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Platform designed to cut cell and gene therapy production costs.

Develops and distributes bioreactor technology for stem cell cultivation.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

AI-enabled technology for cell biology research and biopharma development.

AI platform for industry innovation leaders to navigate science, technology, and innovation landscapes.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Developing human microbiology models for drug discovery.

MyBiotics Pharma develops innovative microbiome-based pharmabiotics and drugs using proprietary bacterial mixes and efficient delivery technologies.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-driven digital twin of embryo development for cell-based therapies.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

AI-powered research assistant for scientific literature review and data extraction.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Mapping cell-cell communication at scale in human tissue.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

AI-driven lab automation for biological research and discovery at scale.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.